Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

WNK1 is an unexpected autophagy inhibitor.

Gallolu Kankanamalage S, Lee AY, Wichaidit C, Lorente-Rodriguez A, Shah AM, Stippec S, Whitehurst AW, Cobb MH.

Autophagy. 2017 May 4;13(5):969-970. doi: 10.1080/15548627.2017.1286431. Epub 2017 Feb 15. Review.

2.

Multistep regulation of autophagy by WNK1.

Gallolu Kankanamalage S, Lee AY, Wichaidit C, Lorente-Rodriguez A, Shah AM, Stippec S, Whitehurst AW, Cobb MH.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14342-14347. Epub 2016 Nov 28.

3.

SIK2 Restricts Autophagic Flux To Support Triple-Negative Breast Cancer Survival.

Maxfield KE, Macion J, Vankayalapati H, Whitehurst AW.

Mol Cell Biol. 2016 Nov 28;36(24):3048-3057. Print 2016 Dec 15.

4.

The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.

Maine EA, Westcott JM, Prechtl AM, Dang TT, Whitehurst AW, Pearson GW.

Oncotarget. 2016 Mar 22;7(12):14708-26. doi: 10.18632/oncotarget.7408.

5.

Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer.

Maxfield KE, Taus PJ, Corcoran K, Wooten J, Macion J, Zhou Y, Borromeo M, Kollipara RK, Yan J, Xie Y, Xie XJ, Whitehurst AW.

Nat Commun. 2015 Nov 16;6:8840. doi: 10.1038/ncomms9840.

6.

Mechanisms promoting escape from mitotic stress-induced tumor cell death.

Sinnott R, Winters L, Larson B, Mytsa D, Taus P, Cappell KM, Whitehurst AW.

Cancer Res. 2014 Jul 15;74(14):3857-69. doi: 10.1158/0008-5472.CAN-13-3398. Epub 2014 May 23.

7.

CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity.

Li Z, Pei XH, Yan J, Yan F, Cappell KM, Whitehurst AW, Xiong Y.

Mol Cell. 2014 Jun 5;54(5):805-19. doi: 10.1016/j.molcel.2014.03.046. Epub 2014 May 1.

8.

The 3M complex maintains microtubule and genome integrity.

Yan J, Yan F, Li Z, Sinnott B, Cappell KM, Yu Y, Mo J, Duncan JA, Chen X, Cormier-Daire V, Whitehurst AW, Xiong Y.

Mol Cell. 2014 Jun 5;54(5):791-804. doi: 10.1016/j.molcel.2014.03.047. Epub 2014 May 1.

9.

Cause and consequence of cancer/testis antigen activation in cancer.

Whitehurst AW.

Annu Rev Pharmacol Toxicol. 2014;54:251-72. doi: 10.1146/annurev-pharmtox-011112-140326. Epub 2013 Oct 11. Review.

PMID:
24160706
10.

Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range.

Wang EC, Sinnott R, Werner ME, Sethi M, Whitehurst AW, Wang AZ.

Nanomedicine. 2014 Feb;10(2):321-8. doi: 10.1016/j.nano.2013.07.012. Epub 2013 Aug 3.

11.

Multiple cancer testis antigens function to support tumor cell mitotic fidelity.

Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW.

Mol Cell Biol. 2012 Oct;32(20):4131-40. Epub 2012 Aug 6.

12.

Environmental sensitivity of Ru(II) complexes: the role of the accessory ligands.

Dixon EN, Snow MZ, Bon JL, Whitehurst AM, DeGraff BA, Trindle C, Demas JN.

Inorg Chem. 2012 Mar 19;51(6):3355-65. doi: 10.1021/ic201114u. Epub 2012 Mar 6.

PMID:
22394071
13.

Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.

Whitehurst AW, Xie Y, Purinton SC, Cappell KM, Swanik JT, Larson B, Girard L, Schorge JO, White MA.

Cancer Res. 2010 Oct 1;70(19):7652-61. doi: 10.1158/0008-5472.CAN-10-0840. Epub 2010 Sep 28.

14.

Symplekin specifies mitotic fidelity by supporting microtubule dynamics.

Cappell KM, Larson B, Sciaky N, Whitehurst AW.

Mol Cell Biol. 2010 Nov;30(21):5135-44. doi: 10.1128/MCB.00758-10. Epub 2010 Sep 7.

15.

Bayesian optimal discovery procedure for simultaneous significance testing.

Cao J, Xie XJ, Zhang S, Whitehurst A, White MA.

BMC Bioinformatics. 2009 Jan 6;10:5. doi: 10.1186/1471-2105-10-5.

16.

The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells.

Whitehurst AW, Ram R, Shivakumar L, Gao B, Minna JD, White MA.

Mol Cell Biol. 2008 May;28(10):3190-7. doi: 10.1128/MCB.02291-07. Epub 2008 Mar 17.

17.

Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome.

Rashid PA, Whitehurst A, Lawson N, Bath PM.

J Stroke Cerebrovasc Dis. 2003 Mar-Apr;12(2):82-7.

PMID:
17903909
18.

Mutations in ERK2 binding sites affect nuclear entry.

Yazicioglu MN, Goad DL, Ranganathan A, Whitehurst AW, Goldsmith EJ, Cobb MH.

J Biol Chem. 2007 Sep 28;282(39):28759-67. Epub 2007 Jul 26.

19.

Synthetic lethal screen identification of chemosensitizer loci in cancer cells.

Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, Minna JD, Michnoff C, Hao W, Roth MG, Xie XJ, White MA.

Nature. 2007 Apr 12;446(7137):815-9.

PMID:
17429401
20.

Harnessing RNAi for analyses of Ras signaling and transformation.

Whitehurst AW, White MA.

Methods Enzymol. 2006;407:259-68.

PMID:
16757330
21.

Antibiotic surveillance of Streptococcus pneumoniae in Mississipi.

Flowers HW, Sullivan DC, Wiggers TB, Whitehurst A.

Clin Lab Sci. 2006 Winter;19(1):5-11.

PMID:
16617552
22.

Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001.

Gillis LM, White HD, Whitehurst A, Sullivan DC.

Am J Med Sci. 2005 Aug;330(2):65-8.

PMID:
16103786
24.

A case-control study of dietary and erythrocyte membrane fatty acids in asthma.

Broadfield EC, McKeever TM, Whitehurst A, Lewis SA, Lawson N, Britton J, Fogarty A.

Clin Exp Allergy. 2004 Aug;34(8):1232-6.

PMID:
15298563
25.

The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.

Whitehurst AW, Robinson FL, Moore MS, Cobb MH.

J Biol Chem. 2004 Mar 26;279(13):12840-7. Epub 2004 Jan 5.

26.

p115 Rho GTPase activating protein interacts with MEKK1.

Christerson LB, Gallagher E, Vanderbilt CA, Whitehurst AW, Wells C, Kazempour R, Sternweis PC, Cobb MH.

J Cell Physiol. 2002 Aug;192(2):200-8.

PMID:
12115726
27.

ERK2 enters the nucleus by a carrier-independent mechanism.

Whitehurst AW, Wilsbacher JL, You Y, Luby-Phelps K, Moore MS, Cobb MH.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7496-501.

28.

Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy.

Kang SK, Chou RH, Dodge RK, Clough RW, Kang HS, Hahn CA, Whitehurst AW, Buckley NJ, Kim JH, Joyner RE, Montana GS, Ingram SS, Anscher MS.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):99-103.

PMID:
12007947
29.

Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.

Robinson FL, Whitehurst AW, Raman M, Cobb MH.

J Biol Chem. 2002 Apr 26;277(17):14844-52. Epub 2002 Jan 31.

30.

Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.

Kang SK, Chou RH, Dodge RK, Clough RW, Kang HL, Bowen MG, Steffey BA, Das SK, Zhou SM, Whitehurst AW, Buckley NJ, Kim JH, Joyner RE, Sarmina I, Montana GS, Ingram SS, Anscher MS.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):937-45.

PMID:
11429221
31.

Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium.

Skinner HJ, Girling KJ, Whitehurst A, Nathanson MH.

Br J Anaesth. 1999 Apr;82(4):542-5.

32.

Are modern imaging techniques over diagnosing ureteropelvic junction obstruction?

Wiener JS, Emmert GK, Mesrobian HG, Whitehurst AW, Smith LR, King LR.

J Urol. 1995 Aug;154(2 Pt 2):659-61.

PMID:
7609149
33.

When the motors fail.

Whitehurst A.

Nurs Times. 1995 Feb 1-7;91(5):48-9. No abstract available.

PMID:
7870608
34.

Control of sodium excretion in patients with cranial diabetes insipidus maintained on desamino-[8-D-arginine]vasopressin.

Sutters M, Brace C, Hatfield E, Whitehurst A, Lightman SL, Peart WS.

Clin Sci (Lond). 1993 Nov;85(5):599-606.

PMID:
8287649
35.

Adjuvant antimicrobial therapy with renal calculus surgery.

Harrison LH, Whitehurst AW, Boyce WH.

J Urol. 1977 Aug;118(2):233-6.

PMID:
894798
36.

Hypoplasia of the major renal conduits.

Boyce WH, Whitehurst AW.

J Urol. 1976 Sep;116(3):352-5.

PMID:
957506
37.

A comparison of two logic symbol coding techniques.

Baker JD, Whitehurst AJ.

J Eng Psychol. 1963 Jan;2(1):22-31. No abstract available.

PMID:
5878149

Supplemental Content

Loading ...
Support Center